Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HOB Biotech GroupSHSE:688656 -2.73%78 Days Inventory is 292.42 as of Mar. 2026, which is 14% above its 10-year median of 257.13. GuruFocus rates SHSE:688656 with a GF Score™ of 78/100 and a GF Value™ of ¥89.36 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 786 Medical Devices & Instruments companies, HOB Biotech Group ranks worse than 68.7% on this metric.
The historical rank and industry rank for HOB Biotech Group's Days Inventory or its related term are showing as below:
SHSE:688656'
s Days Inventory Range Over the Past 10 Years
Min: 239.99 Med: 257.13 Max: 290.42
Current: 241.52
During the past 10 years, HOB Biotech Group's highest Days Inventory was 290.42. The lowest was 239.99. And the median was 257.13.
SHSE:688656's Days Inventory is ranked worse than 68.7% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs SHSE:688656: 241.52
HOB Biotech Group's Days Inventory
declined
from Mar. 2025 (316.40) to Mar. 2026 (292.42).
Inventory Turnover measures how fast the company turns over its inventory within a year.
HOB Biotech Group's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
HOB Biotech Group's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.39.
HOB Biotech Group (SHSE:688656) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
HOB Biotech Group's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
HOB Biotech Group's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
HOB Biotech Group Days Inventory Related Terms
HOB Biotech Group Days Inventory Historical Data
* Premium members only.
The historical data trend for HOB Biotech Group's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688656 vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, HOB Biotech Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HOB Biotech Group Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HOB Biotech Group's Days Inventory distribution charts can be found below:
* The bar in red indicates where HOB Biotech Group's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HOB Biotech Group (SHSE:688656) has a Days Inventory of 292.42 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on HOB Biotech Group and its competitors. This is 14% above median its historical median of 257.13. Over the past decade, HOB Biotech Group's Days Inventory has ranged from 239.99 to 290.42. According to the industry distribution chart, HOB Biotech Group ranks #540 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 68.7%.
Is HOB Biotech Group's Days Inventory too high?
HOB Biotech Group's current Days Inventory of 292.42 is 14% above median its 10-year median of 257.13. Over the past 10 years, this metric has ranged from a low of 239.99 to a high of 290.42. The Medical Devices & Instruments industry median Days Inventory is 179.60. HOB Biotech Group's value of 292.42 is 62.8% above this industry median. Based on the distribution chart, HOB Biotech Group ranks #540 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, HOB Biotech Group has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does HOB Biotech Group's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HOB Biotech Group ranks #540 out of 786 companies for Days Inventory. This places HOB Biotech Group in the lower half of its industry. The industry median Days Inventory is 179.60. HOB Biotech Group's value of 292.42 is 62.8% above this benchmark. Historically, HOB Biotech Group's own Days Inventory has ranged from 239.99 to 290.42 over the past decade. While the company's 10-year median is 257.13 vs. the industry median of 179.60, HOB Biotech Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HOB Biotech Group's current Days Inventory of 292.42 is 62.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on HOB Biotech Group and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HOB Biotech Group's current Days Inventory is 292.42, which is 14% above median its own 10-year median of 257.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HOB Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, HOB Biotech Group (SHSE:688656) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥89.36, compared to a current price of ¥79.04 — trading 11.5% below its estimated fair value. The current Days Inventory is 292.42, which is 14% above median its 10-year median of 257.13 and 62.8% above the Medical Devices & Instruments industry median of 179.60. HOB Biotech Group's overall GF Score™ is 78/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For HOB Biotech Group (SHSE:688656), the current Days Inventory is 292.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HOB Biotech Group (SHSE:688656) Overvalued in 2026?
Based on GuruFocus' analysis, HOB Biotech Group stock appears to be undervalued.
The current stock price of ¥79.04 is trading 11.5% below its estimated GF Value™ of ¥89.36.
GuruFocus considers HOB Biotech Group to be Modestly Undervalued.
Key valuation signals for SHSE:688656:
Days Inventory: 292.42 (14% above median its 10-year median of 257.13)
GF Value™: ¥89.36 vs. price of ¥79.04 (11.5% below fair value)
Industry Position: 62.8% above the Medical Devices & Instruments median (#540 of 786)
No single metric tells the full story. See the SHSE:688656 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.
78GF Score
Get the complete analysis for SHSE:688656
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688656 has been successfully added to your 
